First Citizens Bank & Trust CO Vertex Pharmaceuticals Inc Transaction History
First Citizens Bank & Trust CO
- $6.42 Billion
- Q4 2024
A detailed history of First Citizens Bank & Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 4,836 shares of VRTX stock, worth $2.07 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,836
Previous 25,989
81.39%
Holding current value
$2.07 Million
Previous $12.1 Million
83.89%
% of portfolio
0.03%
Previous 0.19%
Shares
27 transactions
Others Institutions Holding VRTX
# of Institutions
1,710Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11.5 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.91 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.12 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.06 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.85 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $110B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...